Naloxonum [Inn-Latin] en es it fr

Naloxonum [Inn-Latin] Brand names, Naloxonum [Inn-Latin] Analogs

Naloxonum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Naloxonum [Inn-Latin] Chemical_Formula


Naloxonum [Inn-Latin] RX_link

Naloxonum [Inn-Latin] fda sheet

Naloxonum [Inn-Latin] msds (material safety sheet)

Naloxonum_[Inn-Latin] MSDS

Naloxonum [Inn-Latin] Synthesis Reference

No information avaliable

Naloxonum [Inn-Latin] Molecular Weight

327.374 g/mol

Naloxonum [Inn-Latin] Melting Point

200 - 205 oC

Naloxonum [Inn-Latin] H2O Solubility


Naloxonum [Inn-Latin] State


Naloxonum [Inn-Latin] LogP


Naloxonum [Inn-Latin] Dosage Forms


Naloxonum [Inn-Latin] Indication

For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.

Naloxonum [Inn-Latin] Pharmacology

Naloxone is an opiate antagonist and prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine. Naloxone is an essentially pure narcotic antagonist, i.e., it does not possess the "agonistic" or morphine-like properties characteristic of other narcotic antagonists; naloxone does not produce respiratory depression, psychotomimetic effects or pupillary constriction. In the absence of narcotics or agonistic effects of other narcotic antagonists, it exhibits essentially no pharmacologic activity.

Naloxonum [Inn-Latin] Absorption

Well absorbed following intramuscular injection.

Naloxonum [Inn-Latin] side effects and Toxicity

No information avaliable

Naloxonum [Inn-Latin] Patient Information

No information avaliable

Naloxonum [Inn-Latin] Organisms Affected

Humans and other mammals